Trials / Completed
CompletedNCT07023705
MLPR As A Diagnostic Marker For Acute Pulmonary Embolism
Monocyte To Large Platelet Ratio As A Diagnostic Marker For Acute Pulmonary Embolism
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 37 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A retrospective study to assess the utility of hematological marker (monocyte to large platelet ratio) to diagnose patients with pulmonary embolism
Detailed description
The investigators conducted a retrospective review of emergency department records of patients who presented with signs and symptoms suggestive of pulmonary embolism (PE) and underwent CT pulmonary angiography (CTPA) for diagnosis. Hematological laboratory findings obtained prior to any treatment were collected and compared between two groups based on CTPA results: those with confirmed PE (CT positive) and those without PE (CT negative).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Monocyte to Large Platelet Ratio (MLPR) | Admission laboratory values were used to calculate the Monocyte-to-Large Platelet Ratio (MLPR) by dividing the absolute monocyte count by the large platelet count. These values were obtained from blood samples collected before any treatment was administered. |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2024-12-31
- Completion
- 2025-05-31
- First posted
- 2025-06-17
- Last updated
- 2025-06-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07023705. Inclusion in this directory is not an endorsement.